Sanofi SA (SNY)
49.33
+0.32
(+0.65%)
USD |
NASDAQ |
May 06, 16:00
49.33
0.00 (0.00%)
After-Hours: 16:48
Sanofi Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.322B |
| June 30, 2023 | |
| December 31, 2022 | 9.034B |
| June 30, 2022 | 8.219B |
| December 31, 2021 | 8.569B |
| June 30, 2021 | 8.095B |
| June 30, 2020 | 8.101B |
| December 31, 2019 | 8.891B |
| June 30, 2019 | 8.219B |
| December 31, 2018 | 8.305B |
| June 30, 2018 | 7.633B |
| December 31, 2017 | 8.657B |
| December 31, 2016 | 7.729B |
| December 31, 2015 | 8.075B |
| June 30, 2015 | 8.709B |
| December 31, 2014 | 8.693B |
| June 30, 2014 | 9.737B |
| December 31, 2013 | 9.433B |
| June 30, 2013 | 9.923B |
| December 31, 2012 | 9.928B |
| June 30, 2012 | 10.19B |
| Date | Value |
|---|---|
| December 31, 2011 | 10.42B |
| June 30, 2011 | 11.16B |
| December 31, 2010 | 8.654B |
| June 30, 2010 | 8.542B |
| December 31, 2009 | 8.601B |
| June 30, 2009 | 8.238B |
| December 31, 2008 | 7.410B |
| June 30, 2008 | 8.145B |
| December 31, 2007 | 7.158B |
| June 30, 2007 | 7.143B |
| December 31, 2006 | 6.638B |
| June 30, 2006 | 6.726B |
| December 31, 2005 | 5.939B |
| June 30, 2005 | 5.861B |
| December 31, 2004 | 6.036B |
| June 30, 2004 | 2.196B |
| December 31, 2003 | 1.873B |
| June 30, 2003 | 1.781B |
| December 31, 2002 | 1.377B |
| June 30, 2002 | 1.485B |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
8.095B
Minimum
Jun 2021
9.322B
Maximum
Dec 2023
8.556B
Average
8.394B
Median
Accounts Receivable (Quarterly) Benchmarks
| AstraZeneca PLC | 11.07B |
| GSK PLC | 8.624B |
| Regeneron Pharmaceuticals Inc | 5.222B |
| Cellectis SA | 0.569M |
| Denali Therapeutics Inc | 3.42M |